Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.
Condition: Seasonal Allergic Rhinitis Interventions: Combination Product: Azelastine + Mometazone, nasal spray; Combination Product: Momat Rhino Advance Sponsor: Sandoz Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Astelin | Hay Fever | India Health | Mometasone | Nasonex | Research | Slovenia Health